BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen S, Sandford S, Kirman JR, Rehm BHA. Innovative antigen carrier system for the development of tuberculosis vaccines. FASEB J 2019;33:7505-18. [PMID: 30870010 DOI: 10.1096/fj.201802501RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Gonzaga ZJC, Zhang J, Rehm BHA. Intranasal Delivery of Antigen-Coated Polymer Particles Protects against Pseudomonas aeruginosa Infection. ACS Infect Dis 2022;8:744-56. [PMID: 35238554 DOI: 10.1021/acsinfecdis.1c00434] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen S, Quan DH, Wang XT, Sandford S, Kirman JR, Britton WJ, Rehm BHA. Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice. Nanomaterials (Basel) 2021;11:2060. [PMID: 34443891 DOI: 10.3390/nano11082060] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Evert BJ, Chen S, McConville R, Steel RWJ, Healer J, Boddey JA, Huntimer L, Rehm BHA. Epitope-coated polymer particles elicit neutralising antibodies against Plasmodium falciparum sporozoites. NPJ Vaccines 2021;6:141. [PMID: 34845267 DOI: 10.1038/s41541-021-00408-2] [Reference Citation Analysis]
4 Gonzaga ZJC, Merakou C, DiGiandomenico A, Priebe GP, Rehm BHA. A Pseudomonas aeruginosa-Derived Particulate Vaccine Protects against P. aeruginosa Infection. Vaccines (Basel) 2021;9:803. [PMID: 34358220 DOI: 10.3390/vaccines9070803] [Reference Citation Analysis]
5 Li X, Liu S, Yin P, Chen K. Enhanced Immune Responses by Virus-Mimetic Polymeric Nanostructures Against Infectious Diseases. Front Immunol 2022;12:804416. [DOI: 10.3389/fimmu.2021.804416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang X, Liu XY, Yang H, Chen JN, Lin Y, Han SY, Cao Q, Zeng HS, Ye JW. A Polyhydroxyalkanoates-Based Carrier Platform of Bioactive Substances for Therapeutic Applications. Front Bioeng Biotechnol 2021;9:798724. [PMID: 35071207 DOI: 10.3389/fbioe.2021.798724] [Reference Citation Analysis]
7 Chen S, Evert B, Adeniyi A, Salla-Martret M, Lua LH, Ozberk V, Pandey M, Good MF, Suhrbier A, Halfmann P, Kawaoka Y, Rehm BHA. Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity. Adv Healthc Mater 2022;11:e2102089. [PMID: 34716678 DOI: 10.1002/adhm.202102089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wibowo D, Jorritsma SHT, Gonzaga ZJ, Evert B, Chen S, Rehm BHA. Polymeric nanoparticle vaccines to combat emerging and pandemic threats. Biomaterials 2021;268:120597. [PMID: 33360074 DOI: 10.1016/j.biomaterials.2020.120597] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]